Donald Gleason Conference on Genitourinary Malignancies

Format: Live Webinar

This course is planned and hosted by the University of Minnesota, Department of Urology. 

This conference brings together top-notch faculty to share updates and best practices in the interest of advancing our collective knowledge related to early diagnosis, proper staging, and effective treatment of urologic cancers.

1. Identify new approaches for diagnosis and treatment of urologic cancers.
2. Describe the latest therapeutic interventions for urologic cancers.
3. Describe emerging concepts in treatment of advanced urologic cancers.
4. Explain the biology of urologic cancers.
5. Outline strategies for patient discussions regarding the risks and benefits of new and evolving treatment options for urologic cancers.

Credit Designation Statements

American Medical Association (AMA)
This activity has been approved for AMA PRA Category 1 Credit™. Determination of exact number of credits is pending.

American Nurses Credentialing Center (ANCC)
This activity is eligible for ANCC contact hours; the number of hours is pending.

Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Cancellation Policy
If you need to cancel your registration, the registration fee, less a $50 administrative fee, will be refunded if we receive a two-week notice prior to the activity. No refunds will be made after that. 

UMN Office of Continuing Professional Development (OCPD) and/or our partner in providing the activity reserves the right to cancel any activity due to unforeseen circumstances. In the event the activity is cancelled, registration fees will be refunded. UMN OCPD and/or our partner in providing the activity is not responsible for any travel-related costs, charges, or expenses, including but not limited to fees assessed by airline, travel, or lodging agencies.

Special Needs Requests
Special needs can be indicated when registering for an activity. If you missed the special needs field, please email [email protected] with your special needs request as well as the activity you will be attending. Please note requests cannot always be honored on-site.

It is the policy of the University of Minnesota Office of Continuing Professional Development to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals who have influence over activity content are required to disclose to the learners any financial relationships with an ineligible company (formerly known as a commercial interest). Disclosure information is reviewed in advance in order to mitigate any possible conflicts of interest. Specific disclosure information for each presenter, course director, and planning committee member will be shared with learners prior to the start of the course. Persons who fail to complete the disclosure in advance of the course are not eligible to be involved in this course.

Mitigation of Relevant Financial Relationships

University of Minnesota Continuing Professional Development adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and has policies in place to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests); individuals who fail to complete the disclosure in advance of the course are not eligible to be involved in this course. Specific disclosure information will be shared with learners prior to the start of the course. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Faculty Member Information

Role in activity

Name of commercial interest/Nature of relationship

Casey Pratt, BA
University of Minnesota

Activity Coordinator

Nothing to disclose

Christopher Warlick, MD, MPH
University of Minnesota

Course Director, Faculty

I am the PI on a trial for Francis Medical-Francis Medical|Salary-Syros

Hamed Ahmadi, MD
University of Minnesota

Faculty

Disclosure Information Not Available

Emmanuel S Antonarakis, MD
Dr.
University of Minnesota

Faculty

Consulting Fee-Amgen|Consulting Fee-Astellas|Consulting Fee-AstraZeneca|Consulting Fee-Bayer Corporation|Research Grant Recipient-Bristol-Myers Squibb|Research Grant Recipient-Celgene|Consulting Fee-Clovis|Consulting Fee-Dendreon|Consulting Fee-Eli Lilly and Company|Consulting Fee-ESSA|Research Grant Recipient-Genentech, Inc.|Consulting Fee-GlaxoSmithKline|Consulting Fee-Janssen|Research Grant Recipient-Johnson and Johnson|Consulting Fee-Medivation|Consulting Fee-Merck and Company, Inc.|Research Grant Recipient-Novartis AG|Receipt of Intellectual Property Rights/Patent Holder-Qiagen|Consulting Fee-Sanofi-Aventis|Research Grant Recipient-Tokai

Justin Drake, PhD
Dr.
University of Minnesota

Faculty

Nothing to disclose

Shilpa Gupta, MD

Faculty

Disclosure Information Not Available

Elaine T Lam, MD, FACP
Associate Professor
University of Colorado

Faculty

Consulting Fee-Calithera Biosciences|Contracted Research-Bristol-Myers Squibb|Contracted Research-Merck and Company, Inc.|Contracted Research-Roche|Contracted Research-Arrowhead|Contracted Research-Pfizer, Inc.

Drew Rosielle, MD, FAAHPM
Associate Professor
M Health Fairview

Faculty

Nothing to disclose

B. R. Simon Rosser, PhD
Prof.
University of Minnesota

Faculty

Nothing to disclose

Phuoc Tran, MD, PhD
Professor
Johns Hopkins Medicine

Faculty

Consulting Fee-Johnson and Johnson|Consulting Fee-RefleXion Medical|Consulting Fee-AstraZeneca|Consulting Fee-Myovant|Contracted Research-Bayer Corporation|Contracted Research-Astellas|Royalty-Natsar Pharm

Robert Turesky, PhD
University of Minnesota

Faculty

Disclosure Information Not Available

Vanderbilt University, MD, PhD
Dr.
Vanderbilt University Medical Center

Faculty

Speakers Bureau-Pfizer, Inc.

Subodh K Regmi, MBBS, Assistant Professor
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Michael Risk, MD, PhD
University of Minnesota

Faculty, Planning Committee Member

Disclosure Information Not Available

Joseph Zabell, MD
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Jessica Tanner, RN
RN
M Health Fairivew

Nurse Planner

Nothing to disclose

Chinsoo Cho, MD
UMN

Planning Committee Member

Nothing to disclose

Philipp Dahm, MD
UMN

Planning Committee Member

Nothing to disclose

Scott Dehm, PhD
University of Minnesota

Planning Committee Member

Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Johnson and Johnson|Consulting Fee-Oncternal Therapeutics

Charles Ryan, MD

Planning Committee Member

Disclosure Information Not Available

Friday, October 15, 2021

Virtual exhibit opportunities available!